SCHEMBL13660461

SCHEMBL13660461

O=c1c2ncccc2nc([C@H]2C[C@@H]3[C@H](C2)C3(F)F)n1-c1ccc(Cl)nc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.37
USP14 P54578 1/20 0.37
PDE4B Q07343 5/20 0.33
PDE4D Q08499 3/20 0.33
TMEM97 Q5BJF2 1/20 0.33
CYP11B2 P19099 1/20 0.31
POLB P06746 1/20 0.31
CHRNB2 P17787 2/20 0.31
CHRNA4 P43681 2/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
MAT2A P31153 1/20 0.31
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
ITGB1 P05556 1/20 0.30
ITGA4 P13612 1/20 0.30
IDO1 P14902 1/20 0.30
TDO2 P48775 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13660412 0.90 HRH3 (0.40) HRH3USP14PDE4BPDE4DTMEM97
SCHEMBL13660309 0.86 PDE4B (0.43) HRH3USP14PDE4BPDE4D
SCHEMBL13660463 0.86 PDE4B (0.37) HRH3USP14PDE4BPDE4DPOLB
SCHEMBL3174423 0.82 PDE4B (0.36) HRH3USP14PDE4BPDE4DCHRNB2
SCHEMBL3174425 0.82 PDE4B (0.36) HRH3USP14PDE4BPDE4DCHRNB2
SCHEMBL13660308 0.80 CHRNB2 (0.31) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL13660416 0.76 HRH3 (0.42) HRH3USP14PDE4BPDE4DPOLB
SCHEMBL13660414 0.76 SMN1; SMN2 (0.34) PDE4BCYP11B2POLBCHRNB2CHRNA4
SCHEMBL13985504 0.75 CHRNB2 (0.36) USP14CYP11B2POLBCHRNB2CHRNA4
SCHEMBL4756478 0.75 CHRNB2 (0.36) USP14CYP11B2POLBCHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009121036-A2 SUBSTITUTED ARYL PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2009-10-01 WO disclosed